CRI ImmunoAdvocate and lung cancer survivor Oswald Peterson shares his experience with cancer immunotherapy and the importance of choosing where you go for cancer treatment. #CRIsummit #Immunotherapy [ Ссылка ]

No cancer patient has the same story or experience, but knowledge and self-advocacy help every patient on their journey.

In 2017, Oswald Peterson was severely ill and refused to accept the diagnosis of his local urgent care. Wanting the best care possible, he trekked all the way NewYork-Presbyterian/Columbia University Irving Medical Center from his home in Brooklyn, where he was diagnosed with stage 4 non-small cell lung cancer. He had nursed his mother during her battle with cancer, so he thought he knew the options that lay ahead: chemotherapy or radiation. However, his doctor recommended a newly approved PD-1 checkpoint immunotherapy instead, based on an analysis of his tumor’s biomarkers. He received the first infusion in February 2017 during a three-month hospital stay. Moreover, he was never alone in the hospital; his friends came to visit him daily and did not allow him to give up hope. Scans showed that the cancer shrank dramatically after his second infusion. He was able to put weight back on, resume work at his nonprofit, and get back to the gym. Now with no evidence of disease, Oswald receives immunotherapy treatment every nine weeks. He is passionate about spreading the word about cancer immunotherapy research and treatment. He is excited to share lessons on choosing the best care provider, trying new treatments, and getting the support you need along your cancer journey. [ Ссылка ]

In this video, Oswald describes:
- Experience of being diagnosed with stage 4 lung cancer
- Caring for his mother after she was diagnosed with ovarian cancer
- How stress can affect your mental, emotional, and spiritual health
- Importance of choosing where you go for cancer treatment and researching the best available treatments
- Being treated with cancer immunotherapy and common side effects he experienced
- Maintaining a positive mindset while on cancer treatment, with the help and support from friends
- Celebrating his new lease on life after immunotherapy

Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. [ Ссылка ]

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.

свернуть